Newsroom

Here you can find information about our company as well as our latest news and press releases.

It is our ambition to engage in a transparent dialogue with all media representatives, in a timely manner, as far as possible. Feel free to contact us.

Recent articles

All
News
Press release

World Tuberculosis Day 2022

March 24, 2022

News

As one of a few BCG vaccine manufacturers in the world, we are pleased to mark World Tuberculosis (TB) Day on March 24 to raise public awareness about the devastating consequences of tuberculosis (TB), and to step up efforts to end TB globally.

CEO Jesper Helmuth Larsen leaves AJ Vaccines A/S effective 31 January 2022. He will be succeeded by Ole Vahlgren who will assume the responsibility as CEO of AJ Vaccines A/S effective today 1 February 2022. We are pleased to welcome Ole Vahlgren as our new CEO.

Change of guard at AJ Vaccines A/S

February 1, 2022

Press release

CEO Jesper Helmuth Larsen leaves AJ Vaccines A/S effective 31 January 2022. He will be succeeded by Ole Vahlgren who will assume the responsibility as CEO of AJ Vaccines A/S effective today 1 February 2022. We are pleased to welcome Ole Vahlgren as our new CEO.

Celebrating our 5-year anniversary, serving millions of people globally

January 16, 2022

News

Today, five years ago, AJ Vaccines emerged as a new life science company, and thus the first steps were taken towards securing a world free of serious diseases. It has been five eventful years where we as a company have worked purposefully and committed to develop innovative vaccines, diagnostics and therapeutic solutions of the highest quality for the world.

AJ Vaccines participated in the 12th International Conference of the Jordanian Association of Urological Surgeons October 2021 in Amman, Jordan.

Milestone for AJ Vaccines towards strengthening our footprint in Jordan and the Middle East

November 29, 2021

News

AJ Vaccines participated in the 12th International Conference of the Jordanian Association of Urological Surgeons October 2021 in Amman, Jordan.

Celebrating the 100th anniversary of BCG

November 19, 2021

News

2021 is the centennial year of the first administration of Bacillus Calmette-Guérin (BCG). As the BCG vaccine was developed at the Institut Pasteur de Lille under the direction of Albert Calmette and Camille Guérin, the Institute has decided to celebrate this important anniversary in the form of an international scientific symposium on all aspects of BCG from 17-19 November. As one of a few BCG vaccine manufacturers in the world we are pleased to participate.

World Polio Day on October 24 is dedicated to raising awareness of polio vaccination and eradicating polio. AJ Vaccines is a key contributor to the Global Polio Eradication Initiative (GPEI), and today our employees are reminded of the importance of our commitment and hard work to secure a life-saving supply of vaccines to people in need around the world.

AJ Vaccines is committed to World Polio Day 2021

October 24, 2021

News

World Polio Day on October 24 is dedicated to raising awareness of polio vaccination and eradicating polio. AJ Vaccines is a key contributor to the Global Polio Eradication Initiative (GPEI), and today our employees are reminded of the importance of our commitment and hard work to secure a life-saving supply of vaccines to people in need around the world.

Today we are reminded why we work hard every day. AJ Vaccines support World Lung Day to emphasise the importance of early testing and diagnosis of Tuberculosis (TB) to reduce the number of TB cases globally.

World Lung Day 2021 is a strong reminder of why we are here

September 25, 2021

News

Today we are reminded why we work hard every day. AJ Vaccines support World Lung Day to emphasise the importance of early testing and diagnosis of Tuberculosis (TB) to reduce the number of TB cases globally.

AJ Vaccines intend to widen activities in the Middle East Region

December 17, 2020

Press release

AJ Vaccines’ production site-facility in Copenhagen, Denmark has been approved by the Gulf Health Council (GHC) effective 9 November 2020. The approval indicates the vaccine production is at a high standard which will help to secure timely patient access to vaccines in the Gulf Cooperation Council (GCC) countries and wider Middle Eastern region.

World Immunization Week 2020

April 24, 2020

News

‘World Immunization Week’ is particularly relevant this year, as we all face the many challenges brought by the new infectious disease, COVID-19.

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

April 22, 2020

Press release

International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020.

World TB Day 2020

March 20, 2020

News

24th March is World TB Day. In 2018, worldwide, an estimated 10 million people fell ill with TB and 1.5 million died as a result of TB.

AJ Vaccines will contribute to global polio eradication with its innovative vaccine Picovax®

June 28, 2019

Press release

Picovax® has been approved by the Danish Medicines Agency, and the WHO prequalification is expected by the end of 2019, enabling initial delivery of up to 100 million doses globally via UN agencies in 2020-2024.

New CEO at AJ Vaccines A/S

December 1, 2018

News

Jesper Helmuth Larsen replaces Klaus Hermansen as CEO at AJ Vaccines A/S as per 20th December 2018. Jesper Helmuth Larsen previously held the position as Chief Financial Officer in AJ Vaccines, and will continue to assume this responsibility until a new CFO has been found.

AJ Vaccines expands capacity with a comprehensive reconstruction and renovation of its Polio vaccine production

May 14, 2018

Press release

AJ Vaccines has initiated a total reconstruction and expansion of its existing Polio vaccine production facilities. The new facilities will increase production capacity substantially while simultaneously ensuring compliance with future WHO demands for Polio vaccine production and containment.

AJ Vaccines successfully completes two phase III trials of its new low-dose IPV-Al vaccine

March 19, 2018

Press release

The primary objectives in both trials were met successfully and next steps towards documentation, approvals and production can commence to satisfy the global demand for sufficient and affordable IPV vaccine.

AJ Vaccines kicks off its product portfolio expansion with the development of an innovative and pioneering Meningococcal Vaccine

January 25, 2018

Press release

Only one year after the formation of AJ Vaccines, the company will play a central role in the development of a new vaccine that will reshape immunization standards, protecting against five serogroups, which cause meningococcal infections and septicemia.

Media Contact

If you have questions or media inquiries, please contact Steen Vejlgaard, VP People, Communications & EHS.
E: STVE@ajvaccines.com.

Newsroom

Recent articles

World Tuberculosis Day 2022

Change of guard at AJ Vaccines A/S

Celebrating our 5-year anniversary, serving millions of people globally

Milestone for AJ Vaccines towards strengthening our footprint in Jordan and the Middle East

Celebrating the 100th anniversary of BCG

AJ Vaccines is committed to World Polio Day 2021

World Lung Day 2021 is a strong reminder of why we are here

AJ Vaccines intend to widen activities in the Middle East Region

World Immunization Week 2020

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

World TB Day 2020

AJ Vaccines will contribute to global polio eradication with its innovative vaccine Picovax®

New CEO at AJ Vaccines A/S

AJ Vaccines expands capacity with a comprehensive reconstruction and renovation of its Polio vaccine production

AJ Vaccines successfully completes two phase III trials of its new low-dose IPV-Al vaccine

AJ Vaccines kicks off its product portfolio expansion with the development of an innovative and pioneering Meningococcal Vaccine

Media Contact

AJ Vaccines in brief

AJ Vaccines A/S

Quick Links

Information

Follow us